2022.05

Avenir® Plus Coil System Approved by NMPA

2022.04

Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion

2022.03

Esperance™ 6F Aspiration Catheter obtained NMPA approval

2021.12

Setup strategic partnership with Japan Lifeline to achieve a larger scale of development in the Japanese market

2021.11

Esperance™ 5F & 6F Aspiration Catheter obtained FDA 510(k) clearance.

2021.09

Phase 1 of new Shanghai Xingchuang Park facility completed

2021.08

Avenir® Coil System obtained NMPA registration approval and was listed in the Innovative Medical Device Product List, China

2021.08

Signed strategic cooperation with Brainomix in Greater China, taking e-Stroke software as a crucial link in providing whole-process cerebrovascular disease solutions for Stroke clinical patients in China

2021.05

Strategic cooperation with Chinese Association of Cerebrovascular Diseases and Beijing Cerebrovascular Disease Industry Technology Innovation Strategic Alliance

2021.04

Esperance™ Distal Access Catheter Launched in China

2021.01

New Laguna Hills office opened

2020.11

Closed Series C financing from a group of leading healthcare investors.

2020.08

Series B+ financing closed

2020.05

Avenir® Coil System registered with the Taiwan FDA

2020.05

Avenir® Coil System registered in Mexico

2020.04

Avenir® Coil System was registered in Israel

2019.12

The first USA sale of Avenir® Coil System

2019.12

Avenir® Coil System registered in Japan

2019.12

Setup strategic partnership with Phenox (Germany) and signed exclusive licensed distribution agreement in the United States and Europe for Avenir® Coil System

2019.09

Avenir® Coil System receives CE Mark

2019.05

Shanghai Tianxiong Road Factory expansion completed

2019.04

Completed animal study of Esperance™ Aspiration Catheter

2019.02

Qingdai Road Office completed

2018.07

Series B financing closed

2018.07

China Patent of Avenir® Coil System Series granted

2018.05

Avenir® Coil System obtained FDA 510(k) clearance

2018.04

Obtained ISO 13485 Certification

2018.03

Esperance™ Distal Access Catheter prototype sample successfully completed

2017.05

Series A financing closed

2017.01

Wallaby Shanghai Tianxiong Road Factory Complete

2016.11

Avenir® Coil System animal study successfully completed

2016.10

Angel round financing closed.

2016.07

US Provisional Patent, Application for Avenir® Coil System

2016.07

Wallaby China Office setup in Shanghai

2016.06

Functional prototype of Avenir® Coil System completed

2016.01

1st Employee joined Wallaby

2015.12

Wallaby US Setup

Slide left

2022.05

Avenir® Plus Coil System Approved by NMPA

2022.04

Wallaby Acquires German Neurovascular Leader Phenox to Accelerate Global Expansion

2022.03

Esperance™ 6F Aspiration Catheter obtained NMPA approval

2021.12

Setup strategic partnership with Japan Lifeline to achieve a larger scale of development in the Japanese market

2021.11

Esperance™ 5F & 6F Aspiration Catheter obtained FDA 510(k) clearance.

2021.09

Phase 1 of new Shanghai Xingchuang Park facility completed

2021.08

Avenir® Coil System obtained NMPA registration approval and was listed in the Innovative Medical Device Product List, China

2021.08

Signed strategic cooperation with Brainomix in Greater China, taking e-Stroke software as a crucial link in providing whole-process cerebrovascular disease solutions for Stroke clinical patients in China

2021.05

Strategic cooperation with Chinese Association of Cerebrovascular Diseases and Beijing Cerebrovascular Disease Industry Technology Innovation Strategic Alliance

2021.04

Esperance™ Distal Access Catheter Launched in China

2021.01

New Laguna Hills office opened

2020.11

Closed Series C financing from a group of leading healthcare investors.

2020.08

Series B+ financing closed

2020.05

Avenir® Coil System registered with the Taiwan FDA

2020.05

Avenir® Coil System registered in Mexico

2020.04

Avenir® Coil System was registered in Israel

2019.12

The first USA sale of Avenir® Coil System

2019.12

Avenir® Coil System registered in Japan

2019.12

Setup strategic partnership with Phenox (Germany) and signed exclusive licensed distribution agreement in the United States and Europe for Avenir® Coil System

2019.09

Avenir® Coil System receives CE Mark

2019.05

Shanghai Tianxiong Road Factory expansion completed

2019.04

Completed animal study of Esperance™ Aspiration Catheter

2019.02

Qingdai Road Office completed

2018.07

Series B financing closed

2018.07

China Patent of Avenir® Coil System Series granted

2018.05

Avenir® Coil System obtained FDA 510(k) clearance

2018.04

Obtained ISO 13485 Certification

2018.03

Esperance™ Distal Access Catheter prototype sample successfully completed

2017.05

Series A financing closed

2017.01

Wallaby Shanghai Tianxiong Road Factory Complete

2016.11

Avenir® Coil System animal study successfully completed

2016.10

Angel round financing closed

2016.07

US Provisional Patent, Application for Avenir® Coil System

2016.07

Wallaby China Office setup in Shanghai

2016.06

Functional prototype of Avenir® Coil System completed

2016.01

1st Employee joined Wallaby

2015.12

Wallaby US Setup

©2022 Wallaby Medical. All Rights Reserved     Official Wechat

©2022 Wallaby Medical. All Rights Reserved
Official Wechat